William J. Martini

In Telfair v. Tandy, a pro se plaintiff filed a Bivens civil rights action challenging events tied to his federal drug prosecution and related matters, after the court had already granted summary judgment to some defendants. The court dismissed the plaintiff's numerous post-judgment motions, letters, and notices; extended a stay on certain claims; dismissed the remaining unresolved claims without prejudice; directed the plaintiff to submit a clear and concise amended pleading; and imposed a 90-day limited preclusion order while ordering the plaintiff to show cause why broader restrictions should not apply to this case and his future filings. The core reasoning centered on the need to curb the plaintiff's pattern of excessive, repetitive, and voluminous submissions that had burdened the docket in this and related proceedings, while ensuring any viable claims could proceed on a proper pleading.

civil rightsprocedurecriminal law

This case is a putative class action brought by pet owners from multiple states against manufacturers Hartz Mountain Corporation, Sergeant’s Pet Care Products, and Summit Yetpharm, alleging that over-the-counter “spot-on” flea and tick treatments containing pyrethrins harmed or killed their pets. Plaintiffs asserted claims for breach of implied and express warranties, violation of the New Jersey Consumer Fraud Act (against Hartz and Summit only), and unjust enrichment, seeking economic damages for the diminished value of the products. The court ruled on the defendants’ motions to dismiss under Rules 12(b)(6) and 12(b)(2), granting the motions in part and denying them in part after analyzing the sufficiency of the pleadings under the laws of the plaintiffs’ home states and applicable choice-of-law principles. The decision turned on whether the complaint plausibly alleged facts supporting each cause of action, the existence of express warranties, and the applicability of state consumer-protection statutes, while noting regulatory context from an EPA advisory but focusing on the private claims.

torts & liabilitybusiness & regulatoryprocedure

This case is a putative class action by purchasers of spot-on flea and tick pesticide products for pets against manufacturers Farnam and Wellmark, alleging the products caused pet injuries including lethargy, weight loss, hearing loss, and neurological problems, and seeking economic damages based on the products' diminished value. Plaintiffs asserted claims for breach of express warranty, breach of implied warranty of merchantability, unjust enrichment, and violations of the New Jersey Consumer Fraud Act and Illinois Consumer Fraud and Deceptive Business Practices Act. The court granted in part and denied in part the defendants' Rule 12(b)(6) motion to dismiss, dismissing claims against the parent company Central Garden & Pet and the unjust enrichment claim without prejudice while denying dismissal of the remaining claims, after analyzing FIFRA preemption, choice of law, and pleading sufficiency.

business & regulatorytorts & liabilityenvironment

This case concerns a Criminal Justice Act (CJA) voucher submitted by appointed defense counsel Michael Baldassare seeking $99,183.24 for representing defendant Terrence Mosley over three years in a federal drug conspiracy prosecution that ended in a guilty plea. The court reduced the requested compensation to $16,150.67 after determining that the representation was neither sufficiently extended nor complex to justify exceeding the $9,700 case compensation maximum, and that numerous billed hours were excessive, duplicative, or improperly included time from other attorneys. The court explained that it has an obligation under the CJA and Judicial Conference Guidelines to scrutinize vouchers to ensure only reasonable compensation is paid from limited public funds, and it compared the request against typical payments in the district and the facts of this relatively straightforward case.

criminal lawprocedure

The case involved Rabbi Shmuley Boteach and his wife suing Libya, its former UN ambassador, and Colonel Qaddafi, alleging trespass, public and private nuisance, negligence, conversion, and related claims after renovation work on the adjacent Libyan diplomatic residence removed trees and a fence near the property line, along with complaints about the property's prior disrepair and proposed construction. The U.S. District Court granted the defendants' motion to dismiss under Rules 12(b)(1), 12(b)(4), 12(b)(5), and 12(b)(6). Core reasoning included failure to effect proper service on the individual defendants, sovereign immunity barring jurisdiction over Libya under the Foreign Sovereign Immunities Act with no applicable exceptions, and insufficient allegations to state plausible claims for nuisance or other harms, with some requests for injunctive relief rendered moot by cessation of construction.

propertyproceduretorts & liability

This patent infringement case involves plaintiffs Graceway and 3M IPC suing defendant Nycomed over alleged infringement of the '672 Patent, a pharmaceutical formulation patent approved in February 2010, shortly after Nycomed launched a competing generic product. Plaintiffs sought a preliminary injunction after an earlier temporary restraining order was denied. The court denied the motion for a preliminary injunction, finding that plaintiffs engaged in dilatory conduct by delaying notice and filing of suit despite prior knowledge of Nycomed's ANDA application, which could have mitigated potential damages. The court also determined that plaintiffs were unlikely to succeed on the merits because the patent was likely obvious in light of prior art, as supported by the patent examiner's findings and expert evidence on formulation stability. Additional factors, including the balance of hardships and lack of demonstrated irreparable harm, weighed against granting extraordinary injunctive relief.

business & regulatoryprocedure

The case concerns a superseding federal indictment charging attorney Paul Bergrin and several associates with multiple crimes, including conspiracy to murder government witnesses, witness bribery, drug trafficking, prostitution, and mortgage fraud, all framed as racketeering activity under RICO through an alleged "Bergrin Law Enterprise." Defendants moved to dismiss the substantive RICO count and related conspiracy and VICAR counts under Federal Rule of Criminal Procedure 12(b)(3), contending that the indictment failed to adequately plead the required elements of an "enterprise" and a "pattern of racketeering activity." The court examined the alleged schemes spanning 2003 to 2009, noting their separation in time, limited overlap among participants, and distinct purposes, while applying the statutory elements from 18 U.S.C. § 1962(c) to assess whether the pleading sufficiently stated an offense distinct from the underlying predicate acts.

criminal law

This case involves a patent infringement dispute between Graceway Pharmaceuticals and 3M Innovative Products Co. on one side and Nycomed (a Perrigo-related entity) on the other, concerning three patents related to imiquimod formulations used in the Aldara cream product. Graceway alleged that Nycomed's FDA-approved generic bioequivalent, which uses an imiquimod and oleic acid formulation covered by the newly issued '672 Patent (on which Graceway holds an exclusive license but does not practice), infringed that patent, and sought damages plus a temporary restraining order and injunction to protect sales of Aldara. The court denied the motion for a temporary restraining order, reasoning that the plaintiffs delayed bringing suit and seeking relief after the patent issued and FDA approval, that Aldara itself is not protected by the '672 Patent, and that equitable factors including laches weighed against granting emergency relief.

business & regulatoryhealthcare

The case involved petitioner Jose Gonzalez, a lawful permanent resident and Spanish citizen, whose application for naturalization was denied by USCIS on the grounds of alleged false statements regarding a prior marriage; after exhausting administrative appeals, he filed a petition for de novo judicial review under 8 U.S.C. § 1421(c) while removal proceedings were also initiated against him. Respondents moved to dismiss under Rules 12(b)(1) and 12(b)(6), arguing that pending removal proceedings stripped the court of subject matter jurisdiction and that no effective relief could be granted. The court denied the motion, holding that it retained jurisdiction to review the final agency denial of naturalization despite the removal proceedings and that the claim satisfied Article III requirements including redressability. The decision rested on analysis of the interplay between 8 U.S.C. §§ 1421(c) and 1429, relevant case law, and the absence of any statutory bar to district court review.

immigrationprocedure

This case involves a patent dispute where Daiichi Sankyo, the maker of hypertension drugs containing olmesartan medoxomil, sued Mylan for infringing U.S. Patent No. 5,616,599 after Mylan sought to market a generic version. Mylan conceded infringement but claimed the patent was invalid for obviousness under 35 U.S.C. § 103. After a bench trial, the court held that Mylan failed to prove obviousness by clear and convincing evidence, finding that the prior art compounds, such as those in the '902 patent and losartan, did not render the claimed invention obvious due to structural differences and superior properties of olmesartan medoxomil. Consequently, the court ruled the patent valid and infringed.

business & regulatoryhealthcareproperty

This case involved a dispute over a maritime lien on the Barge Exiderdome No. 1, where plaintiff Ironhead Marine performed unpaid shipyard repairs and fabrication work on the vessel at the request of its owner, Hannah Brothers, to prepare it for use in an exhibition tour. Ironhead moved for an interlocutory sale of the arrested vessel to recover the debt, while defendants OSK and Hannah opposed, arguing the lien did not cover the exhibit structures and had been satisfied by accord and satisfaction. The court granted the motion for sale, holding that the repairs qualified as necessaries giving rise to a valid lien that attached to the entire vessel including its appurtenances, that no accord and satisfaction was proven due to lack of evidence of mutual agreement, and that sale was warranted due to the vessel's deterioration, excessive maintenance costs, and undue delay in custody.

propertyprocedurebusiness & regulatory

This multidistrict products liability case arose from a criminal scheme by Biomedical Tissue Services and others to harvest human tissue from cadavers without proper consents or regulatory compliance, leading to processed allografts distributed for surgical use. Recipient plaintiffs sued various defendants in the supply chain, including processors and distributors, asserting tort claims based on alleged harms from potentially contaminated tissue products. The court addressed cross-motions for summary judgment on general causation and related Daubert motions to exclude expert testimony on medical and scientific issues such as disease transmission risks and incubation periods. It granted in part the defendants' motion to exclude four of the plaintiffs' experts and their motion for summary judgment, while reserving decision on the plaintiffs' corresponding motions. The rulings rested on Federal Rule of Evidence 702 standards for expert admissibility and analysis of uncontested facts regarding infection risks for conditions like HIV, hepatitis, and syphilis.

torts & liabilityhealthcareprocedure

In this case, a shareholder in several mutual funds sued the funds' manager, distributor, and parent corporation, alleging violations of section 12(a)(2) of the Securities Act and SEC Rule 10b-5 for failing to disclose "shelf-space" arrangements that provided financial incentives to brokers to sell fund shares. The court had previously granted the defendants' motion to dismiss, holding that no duty to disclose existed. On the plaintiff's motion for reconsideration or leave to amend, the court reaffirmed that no statute or regulation required disclosure of these arrangements and that the funds' prospectuses were not misleading in a way that would necessitate further details to avoid misleading shareholders. The court therefore denied both motions.

business & regulatoryprocedure

The case involved a shareholder suing the managers and distributors of mutual funds, along with their parent company, for failing to disclose "shelf-space" arrangements with brokers that provided financial incentives to sell the funds, allegedly in violation of federal securities laws. The court granted the defendants' motion to dismiss, ruling that the complaint failed to state a claim because the defendants had no obligation to disclose these arrangements under section 10(b) of the Securities Exchange Act or section 12(a)(2) of the Securities Act. The core reasoning was that without a duty to disclose, there could be no primary liability, and thus no derivative liability for the parent company either, leading to dismissal with prejudice.

business & regulatoryprocedure

In Chonko v. Commissioner of Social Security Administration, the plaintiff sought attorney's fees under the Equal Access to Justice Act after his appeal of a denied social security disability benefits claim resulted in a stipulated remand from the Third Circuit, where he had been represented pro bono by a Rutgers Law School clinic team. The Commissioner conceded eligibility for fees but objected that the requested amount was unreasonably high due to excessive hours and that any award should be paid directly to Chonko rather than his counsel. The court reviewed the documented hours, applied reductions for efficiency, calculated rates under EAJA, and concluded the $15,182.96 request was reasonable; it further held that the statute requires the award to go to the prevailing party, Chonko, not the attorneys.

procedure

This case involved a construction contract dispute initially filed by the City of Perth Amboy in state court against Safeco Insurance Company, which Safeco removed to federal court based on diversity jurisdiction. Shortly after, the City filed a related state court action against TAK Construction and sought to join TAK as a defendant in the federal case, which would destroy diversity and require remand. The court applied the four Hensgens factors under 28 U.S.C. § 1447(e) to evaluate the motion for joinder of the non-diverse party: the purpose of the amendment, whether the plaintiff was dilatory, potential prejudice to the plaintiff, and other equitable considerations such as avoiding parallel litigation. After de novo review, the court agreed with the magistrate judge that the factors favored joinder and therefore granted the motion to add TAK and remand the case to state court.

procedurebusiness & regulatory

In United States v. Payne, the defendant was charged with receiving and possessing child pornography under federal statutes after agents searched his home pursuant to a warrant and recovered computer hard drives containing such material. The court denied the defendant's pre-trial motions to suppress the evidence and to dismiss the indictment, then convicted him following a bench trial based on stipulated facts. The core reasoning for denying suppression was that the search warrant affidavit established probable cause through evidence of the defendant's subscription to a known child pornography website, including credit card records and email confirmations, without staleness issues. The motion to dismiss was denied because the charges involved traditional child pornography depicting actual minors, rendering constitutional challenges to related statutes inapplicable.

criminal lawprocedurefree speech

The case involved a police officer and union president who spoke to the media about alleged orders from the police director to conduct illegal, race-based vehicle stops without probable cause or reasonable suspicion, after which he was investigated, suspended for five days, and reassigned. He sued the police director, acting chief, mayor, police department, and city under 42 U.S.C. § 1983 for First Amendment retaliation, the New Jersey Conscientious Employee Protection Act, and the New Jersey Law Against Discrimination, alleging the discipline was unlawful retaliation for protected speech and other violations. The court granted summary judgment on the CEPA claim, which the plaintiff withdrew, but denied summary judgment on the § 1983 and NJLAD claims because disputed issues of material fact existed as to whether the speech was protected and a substantial or motivating factor in the adverse employment actions.

free speechcivil rightslabor & employment

This case involved a dispute over the calculation of pension benefits under an ERISA-governed plan for a former car salesman employed from 1977 to 1991, who was compensated through a draw-against-commissions system. The plaintiff challenged the plan administrator's decision to base his benefits on his average monthly draw rather than his higher average commissions, arguing that the plan documents were ambiguous. The court granted the defendants' motion for summary judgment, denied the plaintiff's cross-motion, and dismissed the complaint with prejudice. It held that the plan documents explicitly excluded commissions from basic remuneration and treated the draw as basic monthly earnings, and that the administrator's interpretation was reasonable under the arbitrary and capricious standard of review applicable to such ERISA claims.

labor & employment

In this multidistrict products liability case involving unscreened human tissue, plaintiffs moved for a court order requiring defendants to provide direct notice to unnamed class members about the need for blood testing due to potential health risks. The court denied the motion. It held that the question of whether and how to issue such notices falls under the primary jurisdiction of the FDA, which has statutory and regulatory authority to oversee product recalls, evaluate health hazards, and determine the content and extent of recall communications under 21 C.F.R. §§ 7.40-7.59. The court relied on the doctrine of primary jurisdiction to defer to the agency's expertise and avoid potential inconsistent notices, directing plaintiffs instead to pursue a citizens' petition with the FDA.

torts & liabilityhealthcarebusiness & regulatory